Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 21 | 2025 | 331 | 4.180 |
Why?
|
| Carcinoma, Pancreatic Ductal | 15 | 2025 | 106 | 2.930 |
Why?
|
| Cell Plasticity | 7 | 2025 | 18 | 1.690 |
Why?
|
| Neoplasms | 4 | 2024 | 1231 | 1.050 |
Why?
|
| Acinar Cells | 4 | 2024 | 8 | 0.990 |
Why?
|
| Tumor Escape | 1 | 2024 | 16 | 0.910 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2024 | 21 | 0.900 |
Why?
|
| Pancreatic Ducts | 4 | 2021 | 30 | 0.900 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2024 | 193 | 0.880 |
Why?
|
| Immune Evasion | 1 | 2024 | 55 | 0.870 |
Why?
|
| Epithelial-Mesenchymal Transition | 7 | 2025 | 62 | 0.860 |
Why?
|
| Cell Lineage | 1 | 2024 | 259 | 0.830 |
Why?
|
| Pancreas, Exocrine | 1 | 2021 | 12 | 0.740 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2021 | 8 | 0.730 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 91 | 0.710 |
Why?
|
| Pluripotent Stem Cells | 1 | 2021 | 68 | 0.710 |
Why?
|
| Mice | 23 | 2025 | 10294 | 0.640 |
Why?
|
| Cell Line, Tumor | 13 | 2025 | 1368 | 0.570 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2016 | 1 | 0.540 |
Why?
|
| Neoplasm Metastasis | 6 | 2025 | 186 | 0.530 |
Why?
|
| Carcinogenesis | 4 | 2024 | 118 | 0.530 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 62 | 0.520 |
Why?
|
| Stromal Cells | 1 | 2016 | 65 | 0.520 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2021 | 474 | 0.520 |
Why?
|
| Chemokines | 1 | 2016 | 93 | 0.510 |
Why?
|
| Animals | 26 | 2025 | 19650 | 0.500 |
Why?
|
| Metaplasia | 3 | 2024 | 18 | 0.500 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 55 | 0.390 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 2053 | 0.370 |
Why?
|
| Mice, Knockout | 6 | 2024 | 1997 | 0.370 |
Why?
|
| Organoids | 2 | 2021 | 40 | 0.370 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 628 | 0.360 |
Why?
|
| Adenocarcinoma | 3 | 2024 | 323 | 0.360 |
Why?
|
| Pancreas | 5 | 2024 | 146 | 0.330 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 140 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 3231 | 0.320 |
Why?
|
| Humans | 24 | 2025 | 59389 | 0.300 |
Why?
|
| Signal Transduction | 7 | 2024 | 2903 | 0.280 |
Why?
|
| Cellular Senescence | 2 | 2024 | 104 | 0.270 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 254 | 0.270 |
Why?
|
| Cell Proliferation | 6 | 2025 | 941 | 0.260 |
Why?
|
| Epithelial Cells | 3 | 2025 | 391 | 0.260 |
Why?
|
| Immunotherapy | 2 | 2024 | 228 | 0.240 |
Why?
|
| Liver Neoplasms | 3 | 2023 | 276 | 0.240 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2024 | 2 | 0.230 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2024 | 17 | 0.230 |
Why?
|
| Tumor Hypoxia | 1 | 2024 | 1 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2024 | 52 | 0.230 |
Why?
|
| Immune Tolerance | 1 | 2024 | 172 | 0.210 |
Why?
|
| Sulfonamides | 1 | 2024 | 120 | 0.210 |
Why?
|
| Hypoalbuminemia | 1 | 2023 | 7 | 0.210 |
Why?
|
| Thermogenesis | 1 | 2024 | 116 | 0.210 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 111 | 0.210 |
Why?
|
| Steroid Hydroxylases | 1 | 2023 | 9 | 0.210 |
Why?
|
| Stress, Physiological | 1 | 2024 | 185 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 339 | 0.200 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 203 | 0.200 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 651 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2023 | 19 | 0.190 |
Why?
|
| Pancreatitis | 2 | 2024 | 95 | 0.190 |
Why?
|
| Genes, myc | 1 | 2021 | 17 | 0.190 |
Why?
|
| Mitochondria | 1 | 2025 | 343 | 0.190 |
Why?
|
| Calcium | 1 | 2025 | 555 | 0.190 |
Why?
|
| Gene Deletion | 3 | 2019 | 293 | 0.190 |
Why?
|
| Fibroblasts | 3 | 2022 | 377 | 0.190 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 49 | 0.190 |
Why?
|
| Protein Isoforms | 2 | 2019 | 192 | 0.190 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 71 | 0.180 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 357 | 0.180 |
Why?
|
| Histones | 1 | 2024 | 457 | 0.180 |
Why?
|
| Mice, Inbred Strains | 1 | 2021 | 179 | 0.180 |
Why?
|
| Esophageal Neoplasms | 1 | 2021 | 79 | 0.180 |
Why?
|
| Cell Differentiation | 3 | 2021 | 1304 | 0.180 |
Why?
|
| Immunity, Innate | 2 | 2024 | 774 | 0.170 |
Why?
|
| Fanconi Anemia Complementation Group N Protein | 1 | 2019 | 1 | 0.170 |
Why?
|
| Calcium Signaling | 1 | 2021 | 153 | 0.170 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 13 | 0.170 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 54 | 0.160 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2019 | 5 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 124 | 0.160 |
Why?
|
| Carcinoma | 1 | 2019 | 116 | 0.160 |
Why?
|
| Regulon | 1 | 2018 | 6 | 0.150 |
Why?
|
| Stem Cells | 2 | 2018 | 255 | 0.150 |
Why?
|
| Catenins | 1 | 2018 | 10 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2024 | 493 | 0.150 |
Why?
|
| SOX9 Transcription Factor | 1 | 2018 | 7 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 402 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 71 | 0.150 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2017 | 6 | 0.140 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 584 | 0.140 |
Why?
|
| Keratin-15 | 1 | 2017 | 2 | 0.140 |
Why?
|
| Interleukins | 1 | 2017 | 80 | 0.140 |
Why?
|
| Interleukin-18 | 1 | 2017 | 71 | 0.140 |
Why?
|
| Esophagus | 1 | 2017 | 50 | 0.140 |
Why?
|
| DNA Damage | 1 | 2019 | 279 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2017 | 190 | 0.130 |
Why?
|
| Smoothened Receptor | 1 | 2016 | 26 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 225 | 0.130 |
Why?
|
| B7-H1 Antigen | 1 | 2016 | 54 | 0.130 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 1151 | 0.130 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2015 | 6 | 0.130 |
Why?
|
| STAT5 Transcription Factor | 1 | 2015 | 14 | 0.130 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 14 | 0.130 |
Why?
|
| Collagen | 1 | 2016 | 115 | 0.130 |
Why?
|
| Phenotype | 2 | 2016 | 1137 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2017 | 300 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2017 | 460 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 386 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2016 | 309 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2023 | 1471 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 170 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 847 | 0.110 |
Why?
|
| Gene Expression | 1 | 2016 | 809 | 0.110 |
Why?
|
| Mice, Nude | 2 | 2024 | 258 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1552 | 0.090 |
Why?
|
| Female | 6 | 2024 | 30724 | 0.090 |
Why?
|
| Cadherins | 2 | 2021 | 68 | 0.080 |
Why?
|
| Cell Movement | 2 | 2021 | 428 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2021 | 289 | 0.070 |
Why?
|
| Regeneration | 2 | 2018 | 93 | 0.070 |
Why?
|
| Mutation | 3 | 2021 | 2456 | 0.070 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2016 | 35 | 0.060 |
Why?
|
| Snail Family Transcription Factors | 1 | 2025 | 28 | 0.060 |
Why?
|
| Citric Acid Cycle | 1 | 2024 | 26 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2025 | 101 | 0.060 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2024 | 19 | 0.060 |
Why?
|
| Cell Survival | 2 | 2017 | 559 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 650 | 0.060 |
Why?
|
| F-Box Proteins | 1 | 2024 | 15 | 0.060 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 16 | 0.060 |
Why?
|
| Male | 5 | 2024 | 27747 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2025 | 170 | 0.060 |
Why?
|
| Methylation | 1 | 2024 | 124 | 0.060 |
Why?
|
| Netrin Receptors | 1 | 2023 | 1 | 0.060 |
Why?
|
| Netrin-1 | 1 | 2023 | 4 | 0.060 |
Why?
|
| Retinoids | 1 | 2023 | 12 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1206 | 0.050 |
Why?
|
| Albumin-Bound Paclitaxel | 1 | 2023 | 1 | 0.050 |
Why?
|
| Hepatic Stellate Cells | 1 | 2023 | 23 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2024 | 191 | 0.050 |
Why?
|
| Edema | 1 | 2023 | 42 | 0.050 |
Why?
|
| Albumins | 1 | 2023 | 34 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2092 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2023 | 90 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2024 | 169 | 0.050 |
Why?
|
| Disease Progression | 2 | 2017 | 1119 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2024 | 743 | 0.050 |
Why?
|
| Precision Medicine | 1 | 2021 | 102 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 179 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 55 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 986 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2020 | 124 | 0.040 |
Why?
|
| Etoposide | 1 | 2019 | 33 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2019 | 40 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2024 | 850 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 914 | 0.040 |
Why?
|
| Oncogenes | 1 | 2018 | 66 | 0.040 |
Why?
|
| Transcriptome | 1 | 2021 | 340 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2018 | 206 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 2017 | 9 | 0.040 |
Why?
|
| Interleukin-15 | 1 | 2017 | 24 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2017 | 20 | 0.040 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2017 | 9 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 50 | 0.030 |
Why?
|
| DNA Repair | 1 | 2019 | 242 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2018 | 211 | 0.030 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2016 | 1 | 0.030 |
Why?
|
| L-Selectin | 1 | 2016 | 14 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2016 | 17 | 0.030 |
Why?
|
| STAT Transcription Factors | 1 | 2016 | 17 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2016 | 35 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2016 | 16 | 0.030 |
Why?
|
| Aged | 2 | 2023 | 13406 | 0.030 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2016 | 26 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 587 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 48 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 188 | 0.030 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2016 | 41 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 297 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 178 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 27 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2016 | 112 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 59 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2016 | 177 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2015 | 52 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 450 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 263 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 125 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 1143 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 121 | 0.030 |
Why?
|
| Actins | 1 | 2016 | 259 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 841 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 346 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 1983 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3067 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 801 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 515 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 805 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 207 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1033 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 883 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 676 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3615 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 16314 | 0.010 |
Why?
|